Durysta (bimatoprost intraocular implant) Coverage
Customize your policy alerts
Sign up for all goldcoasthealthplan policy alerts
Know when goldcoasthealthplan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and Medicare Part B coverage for Durysta, a prostaglandin analog implant used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Providers must submit medical records documenting prior therapies and treatment response.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.